» Articles » PMID: 16493000

Antigen-presenting Property of Mesenchymal Stem Cells Occurs During a Narrow Window at Low Levels of Interferon-gamma

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2006 Feb 24
PMID 16493000
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are mostly found around the vasculature system of the adult bone marrow (BM). They function as immune suppressors, express MHC-II, are phagocytic, and support T-cell cytotoxicity. We hypothesize that these contradictory properties of MSCs are important for BM homeostasis and occur partly through antigen presentation (antigen-presenting cells [APCs]) within a narrow window. Indeed, we have verified APC functions of MSCs to recall antigens, Candida albicans and Tetanus toxoid. The target cells have been identified to be CD4(+) T cells. APC assays with IFNgamma-knockdown MSCs and with anti-IFNgamma receptor confirmed that MHC-II expression requires autocrine stimulation by IFNgamma. During APC functions, as IFNgamma levels become elevated, there was a concomitant decrease in MHC-II on MSCs. This observation was correlated with flow cytometry studies showing a gradual decrease in MHC-II expression as IFNgamma levels were increased. The reduced levels of MHC-II correlated with losses in their allogeneic potential, as indicated in mixed lymphocyte reaction. In summary, endogenous and low levels of IFNgamma are required for MHC-II expression on MSCs, and for APC functions. APC functions occur during a narrow window before IFNgamma levels are increased. The study has implications for BM protection against infection and exacerbated inflammatory responses.

Citing Articles

Mesenchymal Stem Cells with Simultaneous Overexpression of GPX3 and CD47 for the Treatment of Drug-Induced Acute Liver Injury.

Jing Y, Li B, Aierken A, Zhang Z, Han D, Lin Z Vet Sci. 2025; 12(2).

PMID: 40005909 PMC: 11861084. DOI: 10.3390/vetsci12020149.


Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases.

Li L, He Y, Zhao J, Yin H, Feng X, Fan X Clin Rev Allergy Immunol. 2025; 68(1):21.

PMID: 39982546 DOI: 10.1007/s12016-025-09030-9.


Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing.

Hodgson-Garms M, Moore M, Martino M, Kelly K, Frith J NPJ Regen Med. 2025; 10(1):7.

PMID: 39905050 PMC: 11794695. DOI: 10.1038/s41536-024-00382-y.


Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights.

Hoseinzadeh A, Esmaeili S, Sahebi R, Melak A, Mahmoudi M, Hasannia M Stem Cell Res Ther. 2025; 16(1):33.

PMID: 39901306 PMC: 11792531. DOI: 10.1186/s13287-025-04158-z.


Increasing robustness of assay for immnosuppressive effect of mesenchymal stromal/stem cells: The role of inflammatory cytokine production by peripheral blood mononuclear cells.

Sawada R, Kusakawa S, Kusuhara M, Tanaka K, Miura T, Yasuda S Regen Ther. 2025; 28:321-332.

PMID: 39877252 PMC: 11773150. DOI: 10.1016/j.reth.2024.12.016.


References
1.
Nishikawa S, Hashi H, Honda K, Fraser S, Yoshida H . Inflammation, a prototype for organogenesis of the lymphopoietic/hematopoietic system. Curr Opin Immunol. 2000; 12(3):342-5. DOI: 10.1016/s0952-7915(00)00097-2. View

2.
Stagg J, Pommey S, Eliopoulos N, Galipeau J . Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood. 2005; 107(6):2570-7. DOI: 10.1182/blood-2005-07-2793. View

3.
Devine S, Bartholomew A, Mahmud N, Nelson M, Patil S, Hardy W . Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol. 2001; 29(2):244-55. DOI: 10.1016/s0301-472x(00)00635-4. View

4.
Bianco P, Riminucci M, Gronthos S, Robey P . Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001; 19(3):180-92. DOI: 10.1634/stemcells.19-3-180. View

5.
Chow D, Wenning L, Miller W, Papoutsakis E . Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. Biophys J. 2001; 81(2):675-84. PMC: 1301544. DOI: 10.1016/S0006-3495(01)75732-3. View